Summary: The Centers for Medicare & Medicaid Services modified its uroflowmetric evaluations coverage policy, effective May 15, 2026. Here's what billing teams need to do before that date.
CMS uroflowmetric evaluation coverage policy changes don't show up on most billing teams' radar until a denial lands in the queue. This modification touches how Medicare pays for urodynamic diagnostic procedures — the kind that urology and urogynecology practices bill regularly. The policy document does not list specific CPT or HCPCS codes, so you'll need to verify which codes your practice uses for uroflowmetry and cross-reference them against current LCD guidance from your Medicare Administrative Contractor.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | Uroflowmetric Evaluations |
| Policy Code | N/A |
| Change Type | Modified |
| Effective Date | May 15, 2026 |
| Impact Level | Medium |
| Specialties Affected | Urology, Urogynecology, Female Pelvic Medicine, Primary Care (select cases) |
| Key Action | Review uroflowmetry billing guidelines and verify MAC-level LCD alignment before May 15, 2026 |
CMS Uroflowmetric Evaluations Coverage Criteria and Medical Necessity Requirements 2026
The Centers for Medicare & Medicaid Services governs Medicare coverage for uroflowmetric evaluations — diagnostic tests that measure the rate and volume of urine flow to assess lower urinary tract function. This coverage policy applies to Medicare Part B beneficiaries. Coverage turns on whether the procedure meets medical necessity criteria for the patient's documented clinical condition.
Medical necessity for uroflowmetric testing generally requires a documented lower urinary tract symptom (LUTS) that warrants objective diagnostic evaluation before treatment. CMS and its Medicare Administrative Contractors have historically required that uroflowmetry be clinically indicated — not performed as a routine screen. The physician must document the clinical rationale in the medical record before the date of service.
The real issue here is that uroflowmetry sits in a diagnostic gray zone for Medicare. It's covered when it drives a treatment decision. It's not covered when it duplicates information already captured through history, physical exam, or prior testing. Your documentation has to draw that line clearly, and it has to do it before you bill.
Prior authorization is not typically required for uroflowmetric evaluations under Medicare Part B. But that doesn't mean you're clear. MAC-level local coverage determinations add criteria that go beyond what CMS publishes nationally. Check your MAC's LCD before May 15, 2026 — that's where the denial risk actually lives.
CMS Uroflowmetric Evaluations Exclusions and Non-Covered Indications
The policy document does not enumerate specific exclusions. Based on standard CMS coverage policy patterns for urodynamic procedures, non-covered indications typically include:
| # | Excluded Procedure |
|---|---|
| 1 | Uroflowmetry performed without documented LUTS or a clinical indication tied to a diagnosis |
| 2 | Repeat testing within a short interval when no new clinical findings or treatment changes justify it |
| 3 | Screening uroflowmetry in asymptomatic patients |
| 4 | Testing performed as part of a research protocol without separate coverage authorization |
These non-covered patterns don't come from invented criteria — they reflect how CMS medical necessity standards apply to diagnostic procedures broadly. Your MAC's LCD for urodynamic testing will spell out the exact excluded indications for your region. If you're billing across multiple MAC jurisdictions, you need to check each one. The criteria aren't uniform.
Coverage Indications at a Glance
Because the published policy document does not list specific covered indications with associated codes, the table below reflects general CMS coverage policy standards for uroflowmetric evaluations. Verify these against your MAC's LCD before the effective date of May 15, 2026.
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Documented lower urinary tract symptoms (e.g., hesitancy, weak stream, incomplete emptying) | Covered when medically necessary | See MAC LCD | Requires documented clinical indication in the medical record |
| Pre-operative evaluation for urologic procedures | Covered when medically necessary | See MAC LCD | Must be clinically tied to the planned procedure |
| Post-treatment follow-up with new or recurrent symptoms | Covered when medically necessary | See MAC LCD | Repeat testing must reflect a clinical change, not routine surveillance |
| Routine screening in asymptomatic patients | Not Covered | N/A | Does not meet CMS medical necessity standards |
| Repeat testing without documented clinical change | Not Covered | N/A | Claim denial risk is high without documented interval change |
| Research protocol without separate authorization | Not Covered | N/A | Standard CMS research exclusion |
Note: This table reflects general CMS coverage policy patterns. The modified policy document does not list specific indications. Confirm with your MAC LCD.
CMS Uroflowmetric Evaluations Billing Guidelines and Action Items 2026
Uroflowmetric evaluation billing under Medicare is not complicated. It's just precise. The margin between covered and not covered is documentation quality and medical necessity justification. Here's what your team needs to do before May 15, 2026.
| # | Action Item |
|---|---|
| 1 | Identify every CPT code your practice uses for uroflowmetry and related urodynamic testing. The modified policy does not list codes, which means your billing team needs to pull your own charge capture and map it. Look at what you're currently billing for uroflowmetry, uroflowmetry with voiding pressure studies, and any bundled urodynamic evaluations. Know your code set before the effective date. |
| 2 | Pull your MAC's current LCD for urodynamic studies. Your MAC is your real coverage authority for uroflowmetry. National CMS policy sets the floor. Your MAC's local coverage determination sets the actual clinical criteria. Find it, read it, and compare it to your current documentation templates. If your templates don't capture what the LCD requires, fix them before May 15, 2026. |
| 3 | Audit your medical necessity documentation workflow. Every uroflowmetry order needs a documented clinical indication in the record before the date of service. That means the ordering physician's note — not a checkbox on a requisition form — should explain why the test changes the clinical picture. Audit ten recent claims. If the documentation doesn't clearly support medical necessity, your workflow needs to change. |
| 4 | Review your reimbursement rates against the current Medicare Physician Fee Schedule. CMS updates fee schedule values annually. If this policy modification affects how uroflowmetry is valued or bundled, your billing team needs to know the current allowed amounts before May 15, 2026. Compare your contracted reimbursement against the fee schedule to catch any gaps. |
| 5 | Train your front-end billing staff on the claim denial patterns for uroflowmetry. Denials for uroflowmetry typically cite lack of medical necessity or insufficient documentation. Make sure your coders know what CMS and your MAC require in the supporting documentation — especially for repeat testing and post-treatment evaluations. A denial caught at the coding stage costs nothing. A denial caught after submission costs time, staff hours, and sometimes the claim. |
| 6 | If your practice spans multiple MAC jurisdictions, check each MAC's LCD separately. Coverage criteria for uroflowmetric evaluations are not uniform across all Medicare Administrative Contractors. What's covered in one region may require additional documentation in another. If you're not sure how this applies to your patient mix, talk to your compliance officer before May 15, 2026. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Uroflowmetric Evaluations Under This Policy
The policy document provided for this modification does not list specific CPT, HCPCS, or ICD-10 codes.
This is not unusual for a CMS policy modification. Coverage policy documents at the national level sometimes address clinical and medical necessity standards without enumerating every billable code. Code-level coverage guidance for uroflowmetric procedures typically lives in MAC-level LCDs, not in the national policy document itself.
What to Do Instead of a Code Table
Contact your MAC directly or access its LCD database at cms.gov/medicare-coverage-database. Search for "urodynamic" or "uroflowmetry" to find the LCD that applies to your jurisdiction. That document will list the exact CPT codes covered, the ICD-10 diagnosis codes required to establish medical necessity, and any frequency or documentation requirements.
Your billing team should have this LCD on file and should review it every time CMS modifies a related national policy. If you don't have a process for monitoring MAC LCD updates alongside CMS national policy changes, you're working with half the picture.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.